Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial investigating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced urotheli…
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC) [Phase 1, Phase 2]
Results from a Phase 1/2 study evaluating several immunotherapy-based treatments and combinations in patients with urothelial carcinoma (bla…
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 trial results of NUC-3373 in combination with other agents in patients with advanced solid tumors; study status terminated with re…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 clinical trial evaluating pembrolizumab after surgery for localized muscle-invasive bladder cancer and locally advanced urothelial c…
-
CLINICAL_TRIALS trial_result · 2026-07-01Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial investigating pembrolizumab after surgery for localized muscle-invasive bladder cancer and locally advanced urothelial carcino…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial investigating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced urotheli…
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced urothelial …
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Efficacy and Utility of Cxbladder Tests in Hematuria Patients
A completed clinical trial assessing the efficacy and utility of the Cxbladder diagnostic test in patients presenting with hematuria, with r…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies [Phase 1]
This Phase 1 clinical trial update evaluates Bintrafusp alfa (M7824) and PDS01ADC alone and in combination with SBRT in adults with metastat…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley) [Phase 2]
Phase 2 trial evaluating various combinations of avelumab in locally advanced or metastatic urothelial carcinoma; the study is currently act…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies [Phase 2]
Phase 2 clinical trial evaluating a PD-1–blocking monoclonal antibody in combination with a metabolic modulator for several solid tumors is …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria
This ongoing clinical trial from Pacific Edge Limited aims to improve detection and risk stratification for urothelial carcinoma in veterans…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers [Phase 1]
Phase 1 clinical trial update evaluating DS3201 in combination with ipilimumab for metastatic prostate, urothelial, and renal cell cancers.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors [Phase 2]
Phase 2 clinical trial update of ceralasertib (AZD6738) alone and in combination with olaparib or durvalumab in various solid tumors; the st…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma [Phase 3]
Phase 3 study evaluating tislelizumab in combination with chemotherapy versus chemotherapy alone for urothelial carcinoma is currently activ…
-
EMA approval · 2026-04-22EMA Authorised: Keytruda (pembrolizumab) — Merck Sharp & Dohme B.V.
The European Medicines Agency authorised Keytruda (pembrolizumab) for multiple cancer indications, including melanoma, Hodgkin lymphoma, ren…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients
AstraZeneca is conducting a multicenter, non-interventional study in Chinese pan-tumor patients to assess concordance of HER2 IHC testing ac…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study assessing the combination of nivolumab, ipilimumab, and cabozantinib for various rare ge…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study [Phase 3]
A Phase 3 trial (MAIN-CAV) is evaluating the addition of cabozantinib to the immunotherapy drug avelumab for metastatic urothelial cancer, w…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 [Phase 2]
A Phase 2 clinical trial evaluating Disitamab Vedotin alone or with Pembrolizumab for HER2-expressing urothelial carcinoma is currently recr…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Study of DCC-2812 in Participants With Advanced Genitourinary Cancers [Phase 1]
This clinical trial update reports that a Phase 1 study of DCC-2812 in advanced genitourinary cancers (renal cell carcinoma, urothelial carc…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer [Phase 1, Phase 2]
The document describes a Pfizer-sponsored clinical trial investigating PF-08634404 alone or in combination with Enfortumab Vedotin for uroth…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma [Phase 1]
Phase 1 trial update for FX-909 in patients with advanced urothelial carcinoma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01) [Phase 3]
An ongoing Phase 3 trial comparing BL-B01D1 to physician's choice chemotherapy in patients with recurrent or metastatic urothelial carcinoma…
-
CLINICAL_TRIALS other · 2026-04-20Clinical Trial Update: Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 [Phase 3]
Phase 3 trial evaluating disitamab vedotin plus pembrolizumab versus chemotherapy in untreated HER2-expressing urothelial carcinoma; the stu…